AI assistant
DEXCOM INC — Director's Dealing 2014
Aug 28, 2014
30198_dirs_2014-08-28_adc8fab7-7468-4ce6-ba1b-f486a5719a9c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-08-26
Reporting Person: GREGG TERRANCE H (Director, CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-08-26 | Common Stock | S | 5000.0 | $46.0533 | Disposed | 640389 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 395626 | Direct |
| Common Stock | 11461 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $46.03 to $46.10. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F2: Included in this number are 35,547 unvested restricted stock units granted on March 8, 2012, 5,078 of which shall vest each month through March 8, 2015.
F3: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.